Regulus Therapeutics Inc. , which has been struggling for years, said on July 6 that it is cutting its head count by 60%, halting enrollment in its two clinical programs, and reprioritizing its precli
IN VITRO DIAGNOSTICS Mergers & Acquisitions Agilent Technologies Inc. Dako AS Expanding its presence in the diagnostics market, life sciences company Agilent Technologies Inc. will pay $2.2bn in c